A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma (Q43887370)
Jump to navigation
Jump to search
scientific article published on 4 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma |
scientific article published on 4 December 2012 |
Statements
1 reference
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma (English)
1 reference
Rakesh Popat
1 reference
Torben Plesner
1 reference
Faith Davies
1 reference
Gordon Cook
1 reference
Peter Elliott
1 reference
Eric Jacobson
1 reference
Todd Gumbleton
1 reference
Heather Oakervee
1 reference
Jamie Cavenagh
1 reference
4 December 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference